Your browser doesn't support javascript.
Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients.
Jan, Muhammad Y; Sayegh, Skye E; Webb, Hanna T; Adebiyi, Oluwafisayo; Anderson, Melissa D; Mishler, Dennis P; Yaqub, Muhammad S; Taber, Tim; Sharfuddin, Asif A.
  • Jan MY; Division of Nephrology and Hypertension, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Sayegh SE; Division of Nephrology and Hypertension, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Webb HT; Division of Nephrology and Hypertension, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Adebiyi O; Division of Nephrology and Hypertension, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Anderson MD; Division of Nephrology and Hypertension, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Mishler DP; Division of Nephrology and Hypertension, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Yaqub MS; Division of Nephrology and Hypertension, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Taber T; Division of Nephrology and Hypertension, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Sharfuddin AA; Division of Nephrology and Hypertension, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Kidney Int Rep ; 6(9): 2468-2471, 2021 Sep.
Article in English | MEDLINE | ID: covidwho-1284069
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Kidney Int Rep Year: 2021 Document Type: Article Affiliation country: J.ekir.2021.06.012

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Kidney Int Rep Year: 2021 Document Type: Article Affiliation country: J.ekir.2021.06.012